These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
681 related articles for article (PubMed ID: 15221015)
1. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1). Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015 [TBL] [Abstract][Full Text] [Related]
2. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141 [TBL] [Abstract][Full Text] [Related]
3. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471 [TBL] [Abstract][Full Text] [Related]
4. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling. Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411 [TBL] [Abstract][Full Text] [Related]
5. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. Ebisawa T; Fukuchi M; Murakami G; Chiba T; Tanaka K; Imamura T; Miyazono K J Biol Chem; 2001 Apr; 276(16):12477-80. PubMed ID: 11278251 [TBL] [Abstract][Full Text] [Related]
6. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism. Lallemand F; Seo SR; Ferrand N; Pessah M; L'Hoste S; Rawadi G; Roman-Roman S; Camonis J; Atfi A J Biol Chem; 2005 Jul; 280(30):27645-53. PubMed ID: 15946939 [TBL] [Abstract][Full Text] [Related]
7. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K J Clin Invest; 2004 Jan; 113(2):253-64. PubMed ID: 14722617 [TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852 [TBL] [Abstract][Full Text] [Related]
9. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. Seo SR; Lallemand F; Ferrand N; Pessah M; L'Hoste S; Camonis J; Atfi A EMBO J; 2004 Oct; 23(19):3780-92. PubMed ID: 15359284 [TBL] [Abstract][Full Text] [Related]
10. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth. Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727 [TBL] [Abstract][Full Text] [Related]
11. TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Bonni S; Wang HR; Causing CG; Kavsak P; Stroschein SL; Luo K; Wrana JL Nat Cell Biol; 2001 Jun; 3(6):587-95. PubMed ID: 11389444 [TBL] [Abstract][Full Text] [Related]
12. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells. Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856 [TBL] [Abstract][Full Text] [Related]
14. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469 [TBL] [Abstract][Full Text] [Related]
15. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification. Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014 [TBL] [Abstract][Full Text] [Related]
16. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling. Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259 [TBL] [Abstract][Full Text] [Related]
17. Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. Quan T; He T; Voorhees JJ; Fisher GJ J Biol Chem; 2001 Jul; 276(28):26349-56. PubMed ID: 11320083 [TBL] [Abstract][Full Text] [Related]